Tacrolimus Dosing Optimization for Allogeneic Transplant Patients Receiving Post-Transplant Cyclophosphamide

Key Points

• Improved tacrolimus dosing results in better immunosuppression in patients undergoing allogeneic transplant.
• Key evidence shows that optimized dosing reduces complications associated with transplant procedures.
• Observational analysis across multiple transplant centers assessed dosing strategies post-transplant.
• This suggests a need for refined dosing protocols, particularly for patients receiving post-transplant cyclophosphamide.